DiaSorin S.p.A (DIA) - Product Pipeline Analysis, 2014 Update
July 02, 2014 at 11:15 AM EDT
Albany, NY -- (SBWIRE) -- 07/02/2014 -- DiaSorinS.p.A. (DiaSorin) is a medical device company. It undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation. The company offers products grouped under two segments, namely, immunodiagnostics, and molecular diagnostics. Its key products offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA) under immunediagnosticssegmentand extraction, amplification, and diagnostic products under molecular diagnostics segment. The company also develops and distributes immune reagent kits for clinical diagnostics and equipment that are to be used in combination with reagents, to facilitate automatic diagnostic investigation. The companys products address clinical areas such as infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin Group operates through 23 companies and five branches in Europe, the US, Central and South America and Asia. The company is headquartered at Saluggia, Vercelli, Italy.